Ticker Details
Array Technologies, Inc. Array BioPharma Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
IPO Date:	October 15, 2020
Sector:	Technology
Industry:	Solar
Market Cap:	$722.3M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.54 | 3.68%
Avg Daily Range (30 D):	$0.17 | 3.11%
Avg Daily Range (90 D):	$0.26 | 3.53%

Institutional Daily Volume
Avg Daily Volume:	4.54M
Avg Daily Volume (30 D):	6.03M
Avg Daily Volume (90 D):	5.32M

Trade Size
Avg Trade Size (Sh.):	124
Avg Trade Size (Sh.) (30 D):	161
Avg Trade Size (Sh.) (90 D):	136

Institutional Trades
Total Institutional Trades:	6,664
Avg Institutional Trade:	$2.34M
Avg Institutional Trade (30 D):	$2.48M
Avg Institutional Trade (90 D):	$3M
Avg Institutional Trade Volume:	.18M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$5.08M
Avg Closing Trade (30 D):	$4.47M
Avg Closing Trade (90 D):	$5.9M
Avg Closing Volume:	406.64K

News

Jul 22, 2026 @ 1:00 PM ARRAY Announces 60-Degree Solar Tracker Alternativ... Source: Array Technologies

Jun 29, 2026 @ 7:30 AM Solar PV Mounting Systems Market Size to Hit USD 7... Source: Sns Insider

Jun 10, 2026 @ 8:44 PM Tom Lee's Small-Cap Granny Shots ETF Reloads: Firs... Source: Chandrima Sanyal

Feb 10, 2026 @ 3:00 PM Array Acquires Chimney to Expand Digital Financial... Source: Not Specified

Jan 20, 2026 @ 10:10 PM 3 Bold Predictions to Start 2026 Source: Motley Fool Staff

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.97	$.05	$-.09
Diluted EPS	$-.97	$.05	$-.09
Revenue	$1.19B	$342.07M	$223.41M
Gross Profit	$287.61M	$99.6M	$63M
Net Income / Loss	$-85.9M	$24.35M	$2M
Operating Income / Loss	$-60.78M	$34.77M	$7.11M
Cost of Revenue	$897.4M	$242.46M	$160.41M
Net Cash Flow	$-71.47M	$105.31M	$-43.99M
PE Ratio